This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Kumamoto Technology and Industry Foundation, Transgenic Inc.. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Chiemi Minoda: Innovator in Monoclonal Antibodies
Introduction
Chiemi Minoda is a prominent inventor based in Kumamoto, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, her work focuses on innovative solutions for medical applications.
Latest Patents
Chiemi Minoda's latest patents include an anti-diacetylspermine specific monoclonal antibody. This invention provides a specific measuring condition in an immunoreaction system that involves diacetylspermine and the antibody. The system is designed to inhibit the immunoreaction, ensuring accurate measurements. Another notable patent is for a high affinity anti-HIV antibody. This invention targets the gp12 glycoprotein of HIV, offering a pharmaceutical composition that includes the antibody or its fragments. The method of producing this antibody involves immunizing a transgenic non-human mammal with a specific polypeptide.
Career Highlights
Throughout her career, Chiemi Minoda has worked with various organizations, including the Kumamoto Technology and Industry Foundation and Transgenic Inc. Her experience in these institutions has allowed her to advance her research and contribute to significant innovations in her field.
Collaborations
Chiemi has collaborated with notable coworkers such as Shingo Shinagawa and Kazuhiko Kuwahara. These partnerships have played a crucial role in her research and development efforts.
Conclusion
Chiemi Minoda is a remarkable inventor whose work in monoclonal antibodies has the potential to impact medical science significantly. Her innovative patents and collaborations highlight her dedication to advancing biotechnology.